Skip to content
  • Saturday, 31 October 2026
  • 4:09 pm

Signal Press

  • Home
  • Technology
  • Sport
  • Economy
  • Home
  • Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Home
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
0

Markers released top-line results today after previously reporting the trial succeeded.

Read More
Home
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
0

The vaccine reportedly thwarted the cancer's return and spread.

Read More
Home
US wait times for cancer surgeries are getting longer and longer
0

Study finds wait times for cancer surgeries hit 10-year high.

Read More
YOU MAY HAVE MISSED
Home
Once again, NASA is asking for ideas to rescue Hubble from certain death
Home
The FDA wants to pull its approval of a drug. It’s not so easy.
Home
Seabirds racing home over the ocean can get jet-lagged
Home
I’ve Hired Independent Contractors for 20 Years. Here Are 7 Downsides Every Business Owner Should Know

Copyright © 2026 | Powered by WordPress | News Gallery by ThemeArile